Company extends PATSCAN AI Technology to Incorporate Video Solution TORONTO, Nov. 27, 2018 (GLOBE NEWSWIRE) — Patriot One Technologies Inc. (TSX.V: […]
— Initiation of Phase 1/2 Combination Clinical Trial with Evelo’s Monoclonal Microbial, EDP1503, and KEYTRUDA® (pembrolizumab) Across Various Indications Expected […]
NEW HAVEN, Conn., Nov. 27, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing […]